One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1016/j.annonc.2023.02.008
Copy DOI Journal: Annals of Oncology |  Publication Date: Mar 27, 2023 |
Affiliation: Nordic Society of Gynecologic Oncology, Rigshospitalet, Copenhagen University Hospital, Louisiana State University Health Sciences Center Shreveport, McGill University Health Centre, University of Arizona, HonorHealth, Creighton University, Adventist Hinsdale Hospital, A. O. Ordine Mauriziano di Torino, Mount Sinai Medical Center, Florida International University, Indiana University – Purdue University Indianapolis, Indiana University Health, GlaxoSmithKline (United States), University Hospital Schleswig-Holstein, University of Lübeck, Women & Infants Hospital of Rhode Island, Providence College, The US Oncology Network, National Institute of Oncology, Oklahoma Cancer Specialists and Research Institute, Erasmus MC Cancer Institute, University of Southern Denmark, NRG Oncology, National Cancer InstituteVP2-2023: Dostarlimab+chemotherapy for the treatment of primary advanced or recurrent (A/R) endometrial cancer (EC): A placebo (PBO)-controlled randomised phase III trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
